Phase I/II Study of U3-1402 in Subjects With Human Epidermal Growth Factor Receptor 3 (HER3) Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Metastatic Breast Cancer
Related studies linked through entity extraction aliases.
Personalized Molecular Profiling in Cancer Treatment at Johns Hopkins
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- NA
An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study to Evaluate the Efficacy and Safety of Trastuzumab Emtansine in Combination With Atezolizumab or Atezolizumab-Placebo in Participants With Human Epidermal Growth Factor-2 (HER2) Positive Locally Advanced or Metastatic Breast Cancer (BC) Who Received Prior Trastuzumab and Taxane Based Therapy
- Status
- COMPLETED
- Phase
- PHASE2
PalbocIclib in PreMenopausal Women With ER Positive/HER-2 Negative MetAstatic Breast Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Treatment of Metastatic Breast Cancer With Fulvestrant Plus Palbociclib or Tamoxifen Plus Palbociclib
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Fulvestrant 500mg in Patients With Advanced Breast Cancer
- Status
- UNKNOWN
- Phase
- N/A
PAINTER: Polymorphism And INcidence of Toxicity in ERibulin Treatment
- Status
- COMPLETED
- Phase
- PHASE4
Efficacy of the Use of Refrigerant Helmet to Prevent Alopecia in Patients Treated With Eribulin for Breast Cancer
- Status
- TERMINATED
- Phase
- N/A
Low -Dose-bevacizumab and Pemetrexed Versus TPC in Metastatic HER2-negative Breast Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
Quell Opioid Reduction and Pain Relief in Patients With Cancer
- Status
- TERMINATED
- Phase
- NA
Abrogation of Chronic Monoclonal Antibody Treatment-induced T-cell Exhaustion With DURVALUMAB in Advanced HER-2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Expanded Access Program to Provide Abemaciclib (LY2835219) for the Treatment of Metastatic Breast Cancer
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
Eribulin [Halaven] Use For the Treatment of Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- N/A
BP-C1 in Short-term Treatment of Patients With Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Study of Eribulin Mesylate in Combination With PEGylated Recombinant Human Hyaluronidase (PEGPH20) Versus Eribulin Mesylate Alone in Subjects With Human Epidermal Growth Factor Receptor 2 (HER2)-Negative, High-Hyaluronan (HA) Metastatic Breast Cancer (MBC)
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Palliative and Oncology Care Model in Breast Cancer
- Status
- COMPLETED
- Phase
- NA
PQR309 and Eribulin in Metastatic HER2 Negative and Triple-negative Breast Cancer (PIQHASSO)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2